Mobile apps offer learning tools, nutrition education, and real-time monitoring of glucose, and research indicates that digital support interventions can enhance the result of weight loss by 3-5% over pharmacotherapy
Many customers are confused about their products and reach
The Cardio IQ Apolipoprotein B Test, Lipoprotein(a) Test, and hs-CRP Test may refine risk in appropriate patients
There is now a robust evidence base supporting their efficacy in achieving sustained glycemic control and promoting weight loss in patients with T2D [43]
Even though Zepbound and Saxenda are different medications, they share some similarities
The additional benefits for knee pain, fatty liver disease, and cardiovascular risk markers are meaningful